U.S. Post Laser Recovery Products Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 U.S. Post Laser Recovery Products Market Growth & Trends

The U.S. post-laser recovery products market size is expected to reach USD 293.0 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.9% during the forecast period. Post-laser recovery products help to promote the recovery of the skin after undergoing aesthetic procedures.

A post-laser recovery product is designed to help soothe the uncomfortable side effects after ablative and non-ablative laser procedures. Each product has been designed to help to prevent long-term inflammation and minimize pain, itch, and discomfort. The increasing prevalence of skin conditions is a significant factor leading to an increase in the demand for laser treatments which in turn is driving the growth of the post-laser recovery products market.

Immunosuppressed people are more likely to develop skin diseases than healthy people because they are more susceptible to bacterial, fungal, and other disease-causing organisms. Furthermore, a growing number of road accidents and burn cases is also anticipated to drive market growth. As per WHO, approximately 10 million people are disabled or injured due to road accidents every year, which frequently result in scars, requiring surgical treatment.

The market for post-laser recovery products has been severely impacted by the COVID-19 outbreak. The aesthetics industry witnessed significant setbacks due to the COVID-19 pandemic in the first and second quarters of 2020. Lockdowns caused the closure of beauty salons, med spas, dermatological clinics, and retail establishments in various nations because the procedures for cosmetic needs were not medically necessary. Worldwide, hospital management and government representatives asked medical staff to postpone non-emergency appointments. In addition, lockdowns around the world caused numerous retail businesses to close during the first quarter of 2020. Physical store sales were affected as a result.

Request a free sample copy or view report summary: U.S. Post Laser Recovery Products Market Report

U.S. Post Laser Recovery Products Market Report Highlights

• Based on product, cream segment dominated the market in 2022 owing to the higher recommendation of sunscreen and moisturizer for skin recovery, which is the major factor for segment dominance. As per the aesthetician using ceramide creams helps to restore the skin barrier that gets weakened after the laser treatments and also helps in skin regeneration for the skin to heal faster.
• Based on distribution channel, offline channel is dominating the market in 2022. This is due to the fact that a large number of patients still opt for offline distribution of post-laser recovery products as they believe in assessing comfort and finding the best fit for their clinical needs. However, the online segment is likely to have a significant growth rate during the forecast period.
• Key market players include; NeoGenesis, CALECIM Clinic, LA CLINICA, Synergie Skin, RAI Aesthetics, Bynacht, Koru Pharma, Elixir Cosmeceuticals, OxygenCeuticals, Gio Pelle, and Others

Access Press Release@ https://www.grandviewresearch.com/press-release/us-post-laser-recovery-products-market-analysis

U.S. Post Laser Recovery Products Market Segmentation

Grand View Research has segmented the U.S. post-laser recovery products market on the basis of product type, and distribution channel:

U.S. Post Laser Recovery Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cream
• Gel
• Serum
• Others

U.S. Post Laser Recovery Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

List of Key Players of the U.S. Post Laser Recovery Products Market

• NeoGenesis
• CALECIM Clinic
• LA CLINICA
• Synergie Skin
• RAI Aesthetics
• Bynacht
• Koru Pharma
• Elixir Cosmeceuticals
• OxygenCeuticals
• Gio Pelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Post Laser Recovery Products Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 U.S. Post Laser Recovery Products Market Growth & Trends

The U.S. post-laser recovery products market size is expected to reach USD 293.0 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.9% during the forecast period. Post-laser recovery products help to promote the recovery of the skin after undergoing aesthetic procedures.

A post-laser recovery product is designed to help soothe the uncomfortable side effects after ablative and non-ablative laser procedures. Each product has been designed to help to prevent long-term inflammation and minimize pain, itch, and discomfort. The increasing prevalence of skin conditions is a significant factor leading to an increase in the demand for laser treatments which in turn is driving the growth of the post-laser recovery products market.

Immunosuppressed people are more likely to develop skin diseases than healthy people because they are more susceptible to bacterial, fungal, and other disease-causing organisms. Furthermore, a growing number of road accidents and burn cases is also anticipated to drive market growth. As per WHO, approximately 10 million people are disabled or injured due to road accidents every year, which frequently result in scars, requiring surgical treatment.

The market for post-laser recovery products has been severely impacted by the COVID-19 outbreak. The aesthetics industry witnessed significant setbacks due to the COVID-19 pandemic in the first and second quarters of 2020. Lockdowns caused the closure of beauty salons, med spas, dermatological clinics, and retail establishments in various nations because the procedures for cosmetic needs were not medically necessary. Worldwide, hospital management and government representatives asked medical staff to postpone non-emergency appointments. In addition, lockdowns around the world caused numerous retail businesses to close during the first quarter of 2020. Physical store sales were affected as a result.

Request a free sample copy or view report summary: U.S. Post Laser Recovery Products Market Report

U.S. Post Laser Recovery Products Market Report Highlights

• Based on product, cream segment dominated the market in 2022 owing to the higher recommendation of sunscreen and moisturizer for skin recovery, which is the major factor for segment dominance. As per the aesthetician using ceramide creams helps to restore the skin barrier that gets weakened after the laser treatments and also helps in skin regeneration for the skin to heal faster.
• Based on distribution channel, offline channel is dominating the market in 2022. This is due to the fact that a large number of patients still opt for offline distribution of post-laser recovery products as they believe in assessing comfort and finding the best fit for their clinical needs. However, the online segment is likely to have a significant growth rate during the forecast period.
• Key market players include; NeoGenesis, CALECIM Clinic, LA CLINICA, Synergie Skin, RAI Aesthetics, Bynacht, Koru Pharma, Elixir Cosmeceuticals, OxygenCeuticals, Gio Pelle, and Others

Access Press Release@ https://www.grandviewresearch.com/press-release/us-post-laser-recovery-products-market-analysis

U.S. Post Laser Recovery Products Market Segmentation

Grand View Research has segmented the U.S. post-laser recovery products market on the basis of product type, and distribution channel:

U.S. Post Laser Recovery Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cream
• Gel
• Serum
• Others

U.S. Post Laser Recovery Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

List of Key Players of the U.S. Post Laser Recovery Products Market

• NeoGenesis
• CALECIM Clinic
• LA CLINICA
• Synergie Skin
• RAI Aesthetics
• Bynacht
• Koru Pharma
• Elixir Cosmeceuticals
• OxygenCeuticals
• Gio Pelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Japan CDMO Market Witness Excellent Revenue Growth During 2024-2030: Grand View Research Inc

 Japan CDMO Market Growth & Trends

The Japan CDMO market is expected to reach USD 19.49 billion by 2030 and is projected to register a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, a high burden of diseases, and the rising geriatric population are some of the key growth drivers. Growing investments by various Contract Development and Manufacturing Organizations (CDMOs) for facility and service expansion are likely to boost the market over the forecast period.

In addition, increasing pharmaceutical R&D investments are driving the market growth. As pharmaceutical companies invest more in R&D, they may seek external expertise and resources to accelerate drug development processes. CDMOs provide specialized services in drug development, manufacturing, and testing, making them valuable partners for pharmaceutical companies looking to outsource certain aspects of their R&D activities. Several players are investing in the R&D activities of pharmaceuticals. For instance, in March 2022, WuXi AppTec launched Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to accelerate the production of adeno-associated viruses for drugs in cell and gene therapy.

The increase in outsourcing services by pharmaceutical companies in the pharmaceutical industry has profoundly impacted the Japan market.The trend of outsourcing activities in the pharmaceutical domain is rising as companies find value in acquiring additional competencies essential for successful drug development & commercialization. Besides providing extended expertise & assisting in improved cash flow management, outsourcing brings significant manufacturing advantages, including reducing investment risks.

Notably, regulatory authorities in Japan have accelerated approval for regenerative medical and gene therapy products. For instance, the adoption of the Pharmaceuticals and Medical Devices Act (PMD Act), 21st Century Cures Act, and PRIME (Priority Medicines) Initiative has helped the country improve access to regenerative medicines. Such initiatives by regulatory agencies are expected to improve the demand for the development and manufacturing of regenerative medicines in the country.

Request a free sample copy or view report summary: Japan Contract Development And Manufacturing Organization Market Report

Japan CDMO Market Report Highlights

• The active pharmaceutical ingredient (API) segment dominated the market with a share of 81.2% in 2023. The segment growth is driven by competitive drug development and growing demand for end-to-end Contract Development & Manufacturing Organization (CDMO) services. In addition, advancements in API manufacturing, growth of the biopharmaceutical sector, and the increasing geriatric population are some of the key factors propelling segment growth
• Based on workflow, the commercial segment held the largest market share in 2023, attributed to robust demand for pharmaceutical products, such as biosimilar medications, generic medications, and regenerative therapies. This is where commercial CDMOs may help by providing knowledge, saving time, and being cost-effective.
• Based on application, the oncology segment dominated the test type market in 2023 with a revenue share of 35.3%, owing to the high cancer burden in the country. Approval of regenerative products and virotherapy for cancer treatment can further support market growth and the segment is further driven by increasing number of cancer cases globally. In addition, increasing pharmaceutical R&D investments, patent expirations, and demand for oncology drugs & biologic innovations are the factors driving the oncology segment growth

Access Press Release@ https://www.grandviewresearch.com/press-release/japan-contract-development-manufacturing-organization-market-analysis

Japan CDMO Market Segmentation

Grand View Research has segmented the Japan CDMO market based on product, workflow, and application: 

Japan CDMO Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• API
  • Type
    • Traditional Active Pharmaceutical Ingredient (Traditional API)
    • Highly Potent Active Pharmaceutical Ingredient (HP-API)
    • Antibody Drug Conjugate (ADC)
    • Others
  • Synthesis
    • Synthetic
      • Solid
      • Liquid
    • Biotech
  • Drug
    • Innovative
    • Generic
  • Manufacturing
    • Continuous manufacturing
    • Batch manufacturing
  • Drug Product
    • Oral solid Dose
    • Semi-Solid Dose
    • Liquid Dose
    • Others

Japan CDMO Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical
• Commercial

Japan CDMO Application  Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Hormonal
• Glaucoma
• Cardiovascular Diseases
• Diabetes
• Others

List of Key Players in the Japan CDMO Market

• Lonza
• Thermo Fisher Scientific, Inc.
• Recipharm AB
• Laboratory Corporation of America Holdings (LabCorp)
• Catalent, Inc.
• WuXi AppTec, Inc.
• Samsung Biologics
• FUJIFILM Corporation
• Sumitomo Chemical Company, Limited
• CMIC HOLDINGS Co., LTD.
• CordenPharma International
• Cambrex Corporation
• Bushu Pharmaceuticals Ltd.
• Nipro Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Lip Augmentation Market to Incur Meteoric Growth During 2023 to 2030: Grand View Research Inc.

 Lip Augmentation Market Growth & Trends

The global lip augmentation market size is expected to reach USD 11.61 billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. There is increasing demand for cosmetic procedures due to the growing popularity of lip enhancements among both men and women. Today, full and plump lips are considered a desirable aesthetic feature, and individuals seek lip augmentation procedures to achieve the desired look. Moreover, the influence of social media platforms and celebrity culture has further fueled the demand for lip enhancements as people strive to emulate the lip aesthetics of their favorite influencers and celebrities.

This trend has created a lucrative market for lip augmentation products and services, including injectable fillers and surgical procedures, contributing to the growth of the overall market. Apart from the above factors, another driving factor in the market is the advancements in technology and techniques. Innovations in injectable fillers and surgical procedures have made lip augmentation more accessible, safer, and with better outcomes. The availability of a wide range of injectable options, such as hyaluronic acid-based fillers, allows individuals to choose the type of augmentation that best suits their needs and preferences.

Moreover, the minimally invasive nature of these procedures, with shorter recovery times and fewer risks compared to traditional surgeries, has made lip augmentation an attractive option for individuals seeking immediate results with minimal downtime. Overall, the combination of social trends and technological advancements is propelling the growth of the market for lip augmentation, and this trend is expected to continue in the coming years.

Request a free sample copy or view report summary: Lip Augmentation Market Report

Lip Augmentation Market Report Highlights

• Based on type, the temporary augmentation segment accounted for the largest share of 56.22% in 2022 and is expected to witness the fastest growth over the forecast period. It offers people to try different looks without permanent alterations allowing individuals to experiment and align with their aesthetic goals
• In terms of product, the hyaluronic acid fillers segment is expected to grow at the fastest CAGR of around 9.8% during the forecast period. This growth can be attributed to the rising demand for non-surgical cosmetic procedures. Hyaluronic acid fillers are popular as they offer fuller and more defined lips through quick and convenient procedures
• In 2022, the North America region dominated the market for lip augmentation with the growing demand for aesthetic procedures. The desire for enhanced facial features, particularly fuller lips, is a key driver of this market's growth. The impact of social media has significantly popularized plump lips through influencers

Access Press Release@ https://www.grandviewresearch.com/press-release/global-lip-augmentation-market

Lip Augmentation Market Segmentation

Grand View Research has segmented the global lip augmentation market based on type, product, and region:

Lip Augmentation Type Outlook (Revenue, USD Million, 2018 - 2030)

• Temporary
• Permanent
  • Lip Implants
  • Fat Grafting
  • Fillers
  • Lip Advancement
  • Others

Lip Augmentation Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hyaluronic Acid Fillers
• Poly-L-lactic Acid Fillers
• Fat Injection/Lipoinjection
• Lip Collagen
• Others

Lip Augmentation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Lip Augmentation Market

• Allergan
• Galderma Pharmaceuticals S.A
• Merz Pharma Gmbh
• Teoxane Laboratories
• Suneva Medical
• Sinclair Pharma
• Laboratoires Vivacy SAS

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Finance Solutions Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 Healthcare Finance Solutions Market Growth & Trends

The global healthcare finance solutions market size is expected to reach USD 216.4 billion by 2030, registering a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising demand for ongoing improvements and modifications in various healthcare procedures to enhance the efficiency of various healthcare facilities are the factors driving the industry growth. The need for healthcare services is increasing exponentially as a result of the growing aging population and an increase in cases of chronic diseases. The ability to provide the latest edition of medical equipment is essential for maintaining a high standard of patient care.

As hospitals start utilizing the devices of the growing medical technology industry, the ability to finance and lease equipment is becoming even more crucial. It is a crucial component of enabling hospitals and practices to acquire innovations and, as a result, this would create the demand for healthcare finance solutions to invest more in advanced equipment. Real-time access to medical services and related assistance made possible by digital technology could improve the patient experience. This upgrade would require the installation of equipment designed to handle and manage such tasks. With the advancement of technology and the growing demand for advanced healthcare, the cost of the devices would be a major factor for healthcare providers.

The growth of the industry would be greatly impacted by the cost of such devices.The COVID-19 pandemic had severe economic, logistical, and other effects. However, following the pandemic, the industry is putting efforts to invest in the facilities, which include investments in improved forecasting after the supply chain disruptions & shortages, spending more on personnel and safety precautions, such as infrastructure, personnel, and Personal Protective Equipment (PPE). In addition, investments in cybersecurity & remote workforces and in addressing the health disparities that the pandemic has brought to light, such as promoting greater diversity in clinical trials, would support the industry growth.

Request a free sample copy or view report summary: Healthcare Finance Solutions Market Report

Healthcare Finance Solutions Market Report Highlights

• The decontamination equipment segment accounted for the largest revenue share in 2022
• On the basis of healthcare facility type, The hospital & health systems segment accounted for the largest revenue share in 2022
• The equipment and technology finance segment accounted for the largest revenue share of 45.1% in 2022  and accounted for the maximum revenue share in the same year
• This is due to the fact that technology is changing rapidly and the demand for advanced healthcare increases the cost of the equipment
• North America dominated the market and accounted for the largest revenue share of 38.7% in 2022 due to the increased demand for advanced equipment as the institutions adopt the latest devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-finance-solutions-market

Healthcare Finance Solutions Market Segmentation

Grand View Research has segmented the global healthcare finance solutions market on the basis of on equipment type, healthcare facility type, service, and region:

Healthcare Finance Solutions Equipment Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Diagnostic/Imaging Equipment
• Specialist Beds
• Surgical Instruments
• Decontamination Equipment
• IT Equipment

Healthcare Finance Solutions Healthcare Facility Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals & Health Systems
• Outpatient Imaging Centres
• Outpatient Surgery Centres
• Physician Practices & Outpatient Clinics
• Diagnostic Laboratories
• Urgent Care Clinics
• Skilled Nursing Facilities
• Pharmacies
• Other Healthcare Providers

Healthcare Finance Solutions Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment And Technology Finance
• Working Capital Finance
• Project Finance Solutions
• Corporate Lending

Healthcare Finance Solutions Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East And Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Healthcare Finance Solutions Market

• Koninklijke Philips N.V.
• General Electric Company
• Commerce Bancshares, Inc.
• Siemens Financial Services, Inc.
• Thermo Fisher Scientific, Inc.
• Stryker
• Gemino Healthcare Finance
• Oxford Finance LLC
• TCF Capital Solutions
• CIT Group, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trial Biorepository & Archiving Solutions Market Soaring Demand Assures Motivated Revenue Share By 2030

 Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Request a free sample copy or view the report summary: Clinical Trial Biorepository & Archiving Solutions Market Report

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights

• The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
• In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
• The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
• Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trial-biorepository-archiving-solutions-market

Clinical Trial Biorepository & Archiving Solutions Market Segmentation

Grand View Research has segmented the global clinical trial biorepository & archiving solutions market based on service, product, phase, and region:

Clinical Trial Biorepository & Archiving Solutions Service Outlook (Revenue, USD Million, 2018 - 2030)

• Biorepository Services
  • Warehousing & Storage
  • Transportation
  • Sample Processing
  • Others
• Archiving Solution Services
  • Database Indexing and Management
  • Scanning & Destruction

Clinical Trial Biorepository & Archiving Solutions Product Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical Products
• Clinical Products
  • Human Tissue
  • Organs
  • Stem Cells
  • Other Biospecimens

Clinical Trial Biorepository & Archiving Solutions Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Biorepository & Archiving Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Rest of EU
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Rest of MEA

List of Key Players in the Clinical Trial Biorepository & Archiving Solutions Market

• Azenta U.S., Inc.
• Thermo Fisher Scientific Inc. (Patheon)
• Precision for Medicine, Inc.
• Medpace
• LabCorp Drug Development
• ATCC
• Q2 Solutions
• Labconnect
• Charles River Laboratories
• Cell&Co

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-surgical Rhinoplasty Market Booming Trends and Forecast Assessment for the Period 2023 to 2030

 Non-surgical Rhinoplasty Market Growth & Trends

The global non-surgical rhinoplasty market size is expected to reach USD 1.3 billion by 2030, registering a CAGR of 8.1% according to a new report by Grand View Research, Inc. Non-surgical rhinoplasty, also known as liquid rhinoplasty is a non-invasive cosmetic procedure used to alter the shape and define a person’s nose by using injectable fillers such as hyaluronic acid fillers. This method offers immediate results, no downtime, is less invasive, and is inexpensive. All these factors are expected to fuel the growth of the market.

Non-surgical rhinoplasty can be done in case a person has a dorsal bump, asymmetrical shape of the nose, dip in the nose bridge, improve/camouflage deformities, or treat mildly crooked nose. However, this procedure is only carried out to smooth out nasal imperfections and fix minor symmetry issues and cannot treat major nasal defects.

Injectable fillers like HA fillers and CaHa fillers are most commonly used in liquid Rhinoplasty procedures. However, as per Medical News Today, HA injectables are widely preferred and adopted by plastic surgeons and this is because these fillers are biocompatible, have a natural feel, provide a defined shape and complications can be reversed using hyaluronidase injection.

The market witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. However, it is expected to witness a recovery as the demand for non-invasive aesthetic treatments saw significant growth post-pandemic. This is majorly due to increased virtual meets, increased disposable income, high social media impact, and desirability to improve aesthetic appearance. According to the American Society of Plastic Surgeons (ASPS), the pandemic led to an increase in the acceptance of cosmetic procedures

Request a free sample copy or view report summary: Non-surgical Rhinoplasty Market Report

Non-surgical Rhinoplasty Market Report Highlights

• The HA filler segment is projected to dominate the market throughout the forecast period. It is the most preferred and highly adopted filler due to its biocompatibility and aesthetic benefits
• The minor nasal asymmetry application wheelchairs segment is projected to witness rapid growth over the forecast period as slight nasal misalignment due to genetics or minor injuries is expected to be prevalent in the global population
• The MedSpa end-use segment dominated the market owing to comprehensive services offered by such facilities, high accessibility, adoption of advanced products and technology as well as the availability of cost-effective treatments
• North America accounted for the highest revenue share in 2022 due to high awareness about non-invasive aesthetic treatment and the presence of major key players
• Asia Pacific is expected to grow at a CAGR of 8.8% over the forecast period, owing to the rising awareness and adoption of cosmetic treatments in Asian countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-non-surgical-rhinoplasty-market

Non-surgical Rhinoplasty Market Segmentation

Grand View Research has segmented the global non-surgical rhinoplasty market based on filler type, application, end-use and region:

Non-surgical Rhinoplasty Filler Type Outlook (Revenue, USD Million; 2018 - 2030)

• Hyaluronic Acid Fillers
• CaHa Fillers

Non-surgical Rhinoplasty Application Outlook (Revenue, USD Million; 2018 - 2030)

• Indentations of dorsal hump
• Convex Nose
• Minor Nasal Asymmetry
• Others

Non-surgical Rhinoplasty End Use Outlook (Revenue, USD Million; 2018 - 2030)

• MedSpa
• Hospital/Surgery Center
• HCP-owneded clinic

Non-surgical Rhinoplasty Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players Of Non-surgical Rhinoplasty Market

• SKINovative of Gilbert - Medical Spa
• The London Cosmetic Clinic
• Laser Clinic United Kingdom
• Therapie Clinic
• Toronto Cosmetic Clinic (TCC)
• Canada MedLaser, Inc.
• Skin Vitality Medical Clinic
• True MediSpa
• Nova Aesthetic Clinic
• VIVA Skin Clinic
• Piedmont Plastic Surgery & Dermatology

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Spinal Implants And Devices Market to Reach $19.0 Billion by 2030: Grand View Research Inc.

 Spinal Implants And Devices Market Growth & Trends

The global spinal implants and devices market size is expected to reach USD 19.0 billion by 2030, registering a CAGR of 5.4% from 2024 to 2030, according to a new study by Grand View Research, Inc. The growing incidences of spinal cord injuries (SCIs) is a major factor contributing to market growth. For instance, the Centers for Disease Control and Prevention (CDC) estimates that SCIs cost the country around USD 9.7 billion annually.

According to estimates from the National Spinal Cord Injury Association, around 450,000 people in the U.S. are living with spinal cord injuries (SCIs), and about 17,000 new cases are reported annually. This increase in SCI prevalence has led to a higher demand for spinal implants and devices. The World Health Organization (WHO) states that nearly 90% of SCI incidents are due to traumatic events, though the incidence of non-traumatic SCIs is also on the rise. Additionally, it has been noted that between 20% and 30% of individuals with SCI experience significant levels of depression, which negatively impacts their functional recovery and overall well-being. The challenges faced by SCI patients are often exacerbated by limited access to necessary medical care and rehabilitation services.

Advancements in spine surgery technology are driving the expansion of the market. Carlsmed, for example, has launched Aprevo, a cutting-edge interbody solution that comprehensively addresses adult spinal deformity (ASD) through a digital approach. This innovative system utilizes custom 3D-printed implants designed for each patient based on their unique imaging data. Made of titanium, these Aprevo implants are customizable in various aspects, including coronal and lordotic angles, shape, size, and height. Such customization allows for the creation of tailored treatment plans that meet the precise needs of both patients and surgeons, offering an effective approach to managing ASD.

Moreover, introduction of robotic spine surgery, also referred to as robotic-assisted spine surgery has further propelled the market growth. It is a minimally invasive surgical procedure that involves the use of robotic systems to aid the surgeon during the operation. This innovative technique combines the precision and accuracy of robotic technology with the skills and decision-making capabilities of the surgeon and also works as a 3D imaging system.

Request a free sample copy or view report summary: Spinal Implants And Devices Market Report

Spinal Implants And Devices Market Report Highlights

• Based on product, the spinal fusion devices segment accounted for the revenue share of58.4% in 2023 owing to the technological advancements in spine fusion surgery with or without internal fixation
• Based on technology, spinal fusion and fixation technologies segment accounted for the largest market share in 2023. The growth is attributed to their coverage of a broad range of surgical methods, including both posterior and anterior methods
• Based on surgery type, open surgery segment accounted for the largest revenue share in 2023 owing to their flexibility in addressing complex spinal conditions that may require extensive intervention or correction
• Based on procedure type, laminotomy segment accounted for the largest revenue share in 2023 owing to the need to address specific conditions such as spinal stenosis or narrowing of the spinal canal

Access Press Release@ https://www.grandviewresearch.com/press-release/global-spinal-implants-spinal-devices-market

Spinal Implants And Devices Market Segmentation

Grand View Research has segmented the global spinal implants and devices market based on product, technology, surgery type, procedure type, and region:

Spinal Implants And Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Spinal Fusion Devices
  • Thoracic & Lumbar Fusion Devices
  • Cervical Fusion Devices
• Spinal Biologics
  • Allografts
  • Xenografts
  • DBM
  • BMP
  • Synthetic Bone Grafts
• Vertebral Compression Fracture Treatment Devices
• Non-fusion Devices
• Spinal Bone Growth Stimulators

Spinal Implants And Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Spinal Fusion and Fixation Technologies
• Vertebral Compression Fracture Treatment
  • Vertebroplasty
  • Kyphoplasty/Vertebral Augmentation
• Motion Preservation Technologies

Spinal Implants And Devices Surgery Type Outlook (Revenue, USD Million, 2018 - 2030)

• Open Surgery
• Minimally Invasive Surgery

Spinal Implants And Devices Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)

• Discectomy
• Laminotomy
• Foraminotomy
• Corpectomy
• Facetectomy

Spinal Implants And Devices Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Spinal Implants And Devices Market

• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• Globus Medical, Inc.
• Alphatec Spine, Inc
• Orthofix Holdings, Inc
• RTI Surgical Holdings
• Ulrich GmbH & Co. KG
• Braun Melsungen AG
• Seaspine Holdings Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Virtual Cards Market During 2023 – 2030 to Gain Robust Traction: Grand View Research Inc.

 Virtual Cards Market Growth & Trends

The global virtual cards market size is expected to reach USD 60.06 billion by 2030, expanding at a CAGR of 20.9% from 2023 to 2030, according to a new study conducted by Grand View Research, Inc. The increasing usage of digital payment platforms is creating the demand for virtual cards worldwide, which is anticipated to drive the growth of the market. In addition, various types of virtual cards offer the consumer a particular set of benefits, such as efficiency and convenience, which also bodes well for the growth of the market.

Virtual cards are changing the financial landscape by introducing a new level of protection for everyone involved in the payment transaction. Hospitality is one industry that has endorsed the use of virtual cards. Moreover, virtual cards are creating the possibility of making payments more dynamic during the check-in and check-out process for the consumers.

The investments being raised by virtual card solution providers are expected to create new possibilities for the growth of the market during the projected period. For instance, in May 2022, MasterCard and fintech company OPay announced their collaboration, paving the way for access to financial services and economic prosperity by bringing digital commerce to thousands of people in the Middle East and Africa. With this collaboration, OPay consumers and merchants in this region will be able to engage with brands and businesses anywhere in the world.

The COVID-19 pandemic is expected to play a crucial role in driving the growth of the market during the forecast period. People are opting for contactless and digital payments due to the pandemic outbreak, thereby opening new opportunities for the growth of the market. Furthermore, these cards offer contactless payment solutions and are widely accepted at most of the payment gateways and mobile applications such as PayPal and Google Pay which is projected to drive the market growth post-pandemic.

Request a free sample copy or view the report summary: Virtual Cards Market Report

Virtual Cards Market Report Highlights

• The credit card segment is expected to witness the fastest growth during the forecast period. The growing e-commerce businesses worldwide is expected to drive the demand for virtual credit card among consumers, thereby contributing to the segment's growth.
• The B2C remote payment virtual cards segment is expected to witness significant growth during the projected period. The growth of the segment can be attributed to the increasing real-time digital disbursements in mobile platforms worldwide.
• The business use segment is anticipated to dominate the market during the forecast period. Businesses across the globe are adopting virtual card payments to streamline their payment processes and meet their evolving customer needs, which is one of the vital factors that propelled the segmental growth in 2022.
• The Asia Pacific regional market is expected to witness the fastest growth during the projected period. The increasing internet penetration across the region is expected to play a decisive role in driving regional market growth.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-virtual-cards-market

Virtual Cards Market Segmentation

Grand View Research has segmented the global virtual cards market based on card type, product type, application, and region.

Virtual Cards Card Type Outlook (Revenue, USD Million, 2017 - 2030)

• Credit Card
• Debit Card

Virtual Cards Product Type Outlook (Revenue, USD Million, 2017 - 2030)

• B2B Virtual Cards
• B2C Remote Payment Virtual Cards
• C2B POS Virtual Cards

Virtual Cards Application Outlook (Revenue, USD Million, 2017 - 2030)

• Business Use
• Consumer Use

Virtual Cards Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in Virtual Cards Market

• American Express Company
• BTRS Holdings, Inc.
• Wise Payments Limited
• JPMorgan Chase & Co.
• Marqeta, Inc.
• Mastercard
• Skrill USA, Inc.
• Stripe, Inc.
• WEX, Inc.
• Adyen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global MRNA Therapeutics Contract Development & Manufacturing Organization Market to Register Stable Expansion During 2024 – 2030: Grand View Research Inc.

 mRNA Therapeutics Contract Development & Manufacturing Organization Market Growth & Trends

The global mRNA therapeutics contract development & manufacturing organization market size is expected to reach USD 8.35 billion by 2030, registering a CAGR of 11.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing technological advancements in mRNA and cellular delivery systems, coupled with their cost effectiveness, manufacturing simplicity, and ability to target previously undruggable pathways, have limitless potential to revolutionize medicine. This could represent lucrative growth opportunities for the market. Increasing R&D investments to develop mRNA therapeutics and a strong product pipeline are also propelling the market’s growth. For instance, Moderna shared that R&D expenses for the fourth quarter of 2023 increased by 16% to USD 1.4 billion compared to the same quarter of 2022.

The R&D spending was driven by increased clinical manufacturing activities, with the company’s Cytomegalovirus (CMV) vaccine, RSV vaccine, and combination vaccine against COVID-19 & flu, as well as its individualized neoantigen therapy. Such factors are expected to boost research efforts in mRNA therapeutics. In addition, developing novel therapeutics to address unmet medical needs is altering the product market. The rise in molecular complexity drives the need for in-depth knowledge in research and manufacturing services, as well as the technology to enable sustainable expression and scale-up of novel molecular formats. Platform technologies, such as those for bioconjugation or the creation of bispecific antibodies, can drastically shorten development and production times, and customers are looking for skilled CDMOs who can assist them shorten the time to market and reducing investment risk. Consequently, the need for CDMOs to design and produce goods for the pharmaceutical and biotechnology industries is growing exponentially.

Request a free sample copy or view report summary: mRNA Therapeutics Contract Development & Manufacturing Organization Market Report

mRNA Therapeutics Contract Development & Manufacturing Organization Market Report Highlights

• The viral vaccines segment dominated the market with a share of 100.00% in 2023. Growth in the segment can be attributed to the rising availability and launch of various vaccines for the treatment of viral infection (COVID-19)
• The infectious diseases segment held the largest market share in 2023 due to the growing incidence of infectious diseases, several advantages of mRNA vaccine over conventional vaccines, emerging clinical studies & pipeline analysis, and increasing collaboration between pharmaceutical companies & CDMO for production
• The biotech companies end-use segment dominated the market and accounted for a share of more than 60.00% in 2023. The segment growth is driven by increasing strategic initiatives, such as partnerships & collaborations with CDMOs, to manufacture mRNA vaccines
• Asia Pacific is expected to register the fastest growth rate of 10.83% from 2024 to 2030. Due to the rising number of pharmaceutical companies and contract manufacturing organizations in developing countries like India and China, Asia Pacific is likely to overtake Europe and North America in the near future

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mrna-therapeutics-contract-development-manufacturing-market

mRNA Therapeutics Contract Development & Manufacturing Organization Market Segmentation

Grand View Research has segmented the global mRNA therapeutics contract development & manufacturing organization market based on application, indication, end-use, and region:

mRNA Therapeutics CDMO Application Outlook (Revenue, USD Million, 2018 - 2030)

• Viral Vaccines
• Protein Replacement Therapies
• Cancer Immunotherapies

mRNA Therapeutics CDMO Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Diseases
• Metabolic & Genetic Diseases
• Cardiovascular & Cerebrovascular Diseases

mRNA Therapeutics CDMO End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotech Companies
• Pharmaceutical Companies
• Government & Academic Research Institutes

mRNA Therapeutics CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the mRNA Therapeutics Contract Development & Manufacturing Organization Market

• Danaher (Aldevron)
• Biomay AG
• Bio-Synthesis, Inc.
• eTheRNA
• Kaneka Eurogentec S.A.
• TriLink BioTechnologies
• ApexBio Technology
• BioNTech SE
• Biocina
• Lonza
• Recipharm AB.
• Novo Holdings (Catalent, Inc.)
• Samsung Biologics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Camping Cooler Market Is Expected To Accomplish A Valuation Of Around $1,207.9 Million By 2030: Grand View Research Inc.

 Camping Cooler Market Growth & Trends

The global camping cooler market size is expected to reach USD 1,207.9 million by 2030, registering a CAGR of 3.5% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness considerable growth over the forecast period owing to the adoption of innovative technologies for manufacturing chillers and the growing inclination of people spending time outdoors in the wild.

Millennials continue to change the camping landscape through their growing participation in various physical or recreational activities, such as backpacking, mountain biking, and hiking, which is indirectly increasing the popularity of camping iceboxes.

As per Outdoor Industry Association’s report in 2017, the annual consumer spending on outdoor recreational activities in North America amounted to USD 887 billion, which is much higher than the amount spent on essential amenities, including education, fuel, and medical care. It has been observed that annually, around 50% of the U.S. population participates in at least one outdoor activity.

Prominent manufacturers in the camping and outdoor cooler market assemble parts manufactured by third-party vendors and integrate those with their distinctive technology for developing their end product. For instance, Yeti Coolers, LLC outsources product parts from its partners, including Hedstrom Plastics and Solar Plastics, Inc., for manufacturing its rotomolded chillers.

Key camping cooler manufacturers are engaging in retail through e-commerce and brick and mortar stores to expand their product reach. For instance, in February 2017, Yeti Coolers, LLC launched its first retail store in Texas to expand its regional footprint. The store offers an immersive experience to create a permanent brand reputation in the minds of the customer. The store resembles a museum with a variety of products and merchandise displayed, along with marquee exhibits.

Request a free sample copy or view report summary: Camping Cooler Market Report

Camping Cooler Market Report Highlights

• The 50-75 quarts volume segment accounted for a market share of approximately 38.1% in 2022.
• In 2022, Hard coolers are expected to emerge as the dominant segment over the forecast period.
• The dry camping application segment accounted for over 38.8% of the total revenue in 2022.
• The North American region held the maximum share in 2022 and is anticipated to continue its dominance over the camping cooler market over the forecast period.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-camping-cooler-market

Camping Cooler Market Segmentation

Grand View Research has segmented the global camping cooler market on the basis of volume, product, application, and region:

Camping Cooler Volume Outlook (Revenue, USD Million, 2017 - 2030)

• < 25 quart
• 25-50 quart
• 50-75 quart
• 75-100 quart
• > 100 quart

Camping Cooler Product Outlook (Revenue, USD Million, 2017 - 2030)

• Hard Cooler
• Soft Cooler
• Others

Camping Cooler Application Outlook (Revenue, USD Million, 2017 - 2030)

• Dry Camping
• Backpacking
• Off-road/RV Camping
• Others

Camping Cooler Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

List of Key Players in the Camping Cooler Market

• Yeti Coolers, LLC
• AO Coolers
• The Coleman Company Inc.
• Pelican Products Inc.
• Outdoor Active Gear
• Igloo Products Corp
• Grizzly Coolers
• Bison Coolers
• Orca
• Stanley Black & Decker, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.